The room is a Tuesday-morning conference call. The company is a middle-market industrial services business, six quarters into a sponsor's hold period, sitting on a covenant that will trip if the next quarter comes in short. The sponsor is on the line. The CEO is on the line. The CFO is on the line. The independent chairman is on the line, and so is the audit committee chair. And by the end of the hour, it becomes clear that the board has three problems the sponsor did not expect to have — the audit chair does not understand the covenant math, the independent chairman is not close enough to the operations to weigh in on the fix, and the operating specialist who was close enough was quietly rotated off the board a year ago because he asked hard questions.
That last decision was the one that decided the outcome.
The Misunderstanding About Board Composition
Most middle-market boards are composed against biographies rather than against jobs. The independent chairman was a marquee name at the last portfolio company, so he gets the seat here. The audit chair was the CFO of a public company two decades ago, so he gets the audit chair here. The operating specialist was helpful during diligence, so he stays. The board is a stack of resumes, and the stack looks respectable in the deck the sponsor shows the LP.
That is the wrong test. The right test is whether the composition can carry the two or three days a year that actually decide the return. A board that reads well on a resume but cannot function on the Tuesday-morning covenant call is not a board — it is a lineup.
The mistake compounds because it is expensive to correct. Rotating a director off a middle-market board is a real disruption — legal, relational, optical — and the sponsor knows it, so the composition tends to freeze early and then drift toward the mean over the hold. The composition that gets the sponsor to close the deal is often not the composition that gets the company through the crisis. And by the time the crisis reveals it, it is too late to fix cheaply. (This is the same argument we made from the special-situations angle in Special Situations: Where Governance Creates Alpha.)
The Four Questions Composition Should Be Tested Against
The institutional discipline that produces good boards in middle-market private equity is not glamorous. It comes down to answering four questions, in writing, before any director is invited.
Who is the person who takes the 11pm call from the lead lender? That determines the profile of the independent chairman. It is not the marquee name. It is the person whose voice the agent bank already knows, who has the credibility to negotiate a covenant amendment in real time, and who understands the difference between a technical trip and a substantive breach. Middle-market boards routinely pick chairmen who cannot make that call. The seat should be filled against the call, not against the biography.
Who does the CFO trust to review the reforecast? That determines the audit chair. Middle-market audit chairs are frequently people who ran clean audit committees at larger companies. That is not what the seat requires here. It requires someone who can sit with the CFO for two hours on a Sunday afternoon and pressure-test a thirteen-week cash forecast to the dollar, and who has the operating experience to know which line items are actually the risk. The right audit chair for a $500M company is a former operator, not a former Fortune 500 audit committee chair.
Who is close enough to the operations to reforecast the base case without the CEO in the room? That determines the lead independent director. In the covenant-trip meeting, the sponsor needs at least one director who can construct the operating scenario independently. Not to overrule the CEO, but to give the sponsor and the lenders a second, credible read on the numbers. Boards without that seat end up doing the CEO's math and calling it independence. (The companion discipline — where structured-credit boards should look for economic risk — is the argument in The Board Question Structured Credit Should Ask More Often.)
Who has the network to unlock the strategic option if the base case fails? That determines the fourth-seat archetype. It is the director who can pick up the phone and reach the strategic acquirer, the specialty lender, the sponsor secondary, the placement agent. Middle-market boards frequently do not have this seat at all, or they fill it with someone whose network has decayed. The seat exists to keep options open in the quarters when the operating plan alone is not enough.
Four questions, four seats, four testable answers. Any director on the board should be defensible against one of the four. Any director who is not defensible against any of them is a courtesy seat, and courtesy seats are the ones that create the Tuesday-morning problem.
The Role-Shape Framework
The composition test is not about who the directors are — it is about what the board does on the two or three days a year that matter. A useful frame:
Independent Chairman — owns the lender relationship and the board's external voice on hard days.
Audit Committee Chair — owns the reforecasting cadence and the operating economics review.
Lead Independent Director — owns the independent read on the base case and the CEO-succession question in the background.
Operating Specialist — owns the tactical operating levers and the sector-specific pattern recognition.
A middle-market board of four seats, tested against these four role-shapes, will out-govern a board of seven seats composed against biographies. The math is not intuitive — sponsors regularly assume that more seats mean more governance. It does not. More seats mean more diffusion of responsibility, more meetings to coordinate, more inertia against the correction the composition needs. Four well-tested seats beat seven ceremonial ones in every measurable dimension. (This is play 2 in Fireworks from a $45 Billion Institutional Playbook — board composition as a capital-structure decision, not a governance courtesy.)
“A board is worth what it can carry on the two or three days a year that decide the return. Composition is not about biographies. It is about which four questions the seats are testable against.”
What Not to Do
The failure modes are consistent and worth naming.
The celebrity director — the marquee name whose calendar rarely permits the granular work the middle market requires. Signal-to-noise low. Read the biography, decline the invitation.
The ceremonial audit chair — the former public-company CFO whose experience does not translate to reading a middle-market thirteen-week cash forecast. Right seat, wrong occupant. The audit chair for a $500M company is an operator, not a chair-collector.
The friend of the founder — the operating chairman who is loyal to the CEO before he is loyal to the board. Middle-market sponsors accept this seat too often as part of the founder-friendly narrative. It costs on the Tuesday morning that decides the return.
The stacked-resume board — the board where every director has a compelling biography and no director is defensible against any of the four questions above. This is the failure mode most middle-market boards are drifting toward, because biographies are what get boards approved by the sponsor's LP committee. Approval-easy is not governance-strong.
The Compounding
Board composition is one of the few middle-market decisions where the marginal work compounds. A well-tested board saves the covenant trip in year two, which allows the operational fix in year three, which allows the strategic option in year four. A ceremonial board flips the sign on all three. The composition is not a symbolic decision. It is a capital-structure decision, and it compounds against the return with the same slope that the capital structure itself does.
At Pluribus Capital, board composition begins with the four questions, and the seats are tested against the specific Tuesday morning the board will eventually need to run. The biographies are useful modifiers. They are not the substance. The substance is what the seats can carry when the covenant trips at 11pm on a Sunday and the lead lender is waiting for a number.
Ronald Hoplamazian is the Managing Member of Pluribus Capital LLC, a Philadelphia-based merchant bank specializing in structured finance and special situations investing. He previously spent 13+ years at GE Capital, where he served as a board member in over 100 portfolio companies. He can be reached at ron@pluribuscapitalllc.com.